PL2047857T3 - Środek przeznaczony do wstrzykiwania zawierający antybiotyk i roztwór do wstrzykiwania zawierający środek - Google Patents

Środek przeznaczony do wstrzykiwania zawierający antybiotyk i roztwór do wstrzykiwania zawierający środek

Info

Publication number: PL2047857T3
Authority: PL; Poland
Prior art keywords: injection; agent; wap; solution; composition
Prior art date: 2006-06-29

Application number

PL07767796T

Other languages

English (en)

Inventor

Hirofumi Nakajima

Haruhiko Machida

Original Assignee

Kyoto Biopharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-29

Filing date

2007-06-28

Publication date

2012-05-31

2007-06-28 Application filed by Kyoto Biopharma Inc filed Critical Kyoto Biopharma Inc

2012-05-31 Publication of PL2047857T3 publication Critical patent/PL2047857T3/pl

Links

238000002347 injection Methods 0.000 title abstract 3
239000007924 injection Substances 0.000 title abstract 3
239000000243 solution Substances 0.000 title abstract 3
230000003115 biocidal effect Effects 0.000 title abstract 2
239000003795 chemical substances by application Substances 0.000 title 2
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
229920000858 Cyclodextrin Polymers 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 2
108010002156 Depsipeptides Proteins 0.000 abstract 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
239000008121 dextrose Substances 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
238000001802 infusion Methods 0.000 abstract 1
238000001990 intravenous administration Methods 0.000 abstract 1
229910000403 monosodium phosphate Inorganic materials 0.000 abstract 1
235000019799 monosodium phosphate Nutrition 0.000 abstract 1
239000003002 pH adjusting agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 abstract 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
239000003381 stabilizer Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL07767796T 2006-06-29 2007-06-28 Środek przeznaczony do wstrzykiwania zawierający antybiotyk i roztwór do wstrzykiwania zawierający środek PL2047857T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2006179778		2006-06-29
EP07767796A EP2047857B1 (en)	2006-06-29	2007-06-28	Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent
PCT/JP2007/063003 WO2008001849A1 (en)	2006-06-29	2007-06-28	Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent

Publications (1)

Publication Number	Publication Date
PL2047857T3 true PL2047857T3 (pl)	2012-05-31

Family

ID=38845613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL07767796T PL2047857T3 (pl)	2006-06-29	2007-06-28	Środek przeznaczony do wstrzykiwania zawierający antybiotyk i roztwór do wstrzykiwania zawierający środek

Country Status (17)

Country	Link
US (1)	US7968588B2 (pl)
EP (1)	EP2047857B1 (pl)
JP (1)	JP5272126B2 (pl)
KR (1)	KR101286038B1 (pl)
CN (1)	CN101578103B (pl)
AT (1)	ATE539761T1 (pl)
AU (1)	AU2007266063B2 (pl)
BR (1)	BRPI0713080A2 (pl)
CA (1)	CA2656604C (pl)
DK (1)	DK2047857T3 (pl)
ES (1)	ES2378279T3 (pl)
MX (1)	MX2009000155A (pl)
PL (1)	PL2047857T3 (pl)
PT (1)	PT2047857E (pl)
RU (1)	RU2462261C2 (pl)
SI (1)	SI2047857T1 (pl)
WO (1)	WO2008001849A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101931880A (zh)	2009-06-19	2010-12-29	中兴通讯股份有限公司	一种多媒体广播组播业务动态复用的资源分配方法
JP5878302B2 (ja) *	2010-05-25	2016-03-08	株式会社ゲノム創薬研究所	新規環状ペプチド化合物とその製造方法及び感染症治療薬
JP5878303B2 (ja) *	2010-05-25	2016-03-08	株式会社ゲノム創薬研究所	抗生物質含有画分、その抗生物質及びその抗生物質の製造方法
US12070447B2 (en) *	2016-12-14	2024-08-27	Sk Biopharmaceuticals Co., Ltd.	Parenteral liquid preparation comprising carbamate compound
US10975121B2 (en)	2017-06-24	2021-04-13	Cytogel Pharma, Llc	Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
ES2969958T3 (es) *	2017-11-30	2024-05-23	Cytogel Pharma Llc	Formulaciones farmacéuticas analgésicas novedosas y usos de las mismas
KR102434276B1 (ko)	2017-12-08	2022-08-18	엘지디스플레이 주식회사	표시장치
CN112236163B (zh) *	2018-06-13	2024-07-02	京都生物制药株式会社	使用协同量的硼酸增强缩酚酸肽抗生素的抗菌作用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3339235B2 (ja) *	1994-02-18	2002-10-28	日本メディカルリサーチ株式会社	抗生物質ｗａｐ−８２９４ａ、その製造法及び抗菌剤
KR100225601B1 (ko) *	1995-02-02	1999-10-15	오쿠다 기요아키	항생물질 wap-8294a와 이의 제조방법 및 항균조성물
JP4270588B2 (ja)	1996-11-14	2009-06-03	康武日地	神経毒軽減麻酔剤
EP0838225A3 (en)	1996-10-25	1999-03-24	Hiji, Yasutake	Aqueous local anesthetic solution
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
CN1360505A (zh) *	1999-04-15	2002-07-24	伊莱利利公司	假单胞霉素抗真菌组合物和它们的使用方法
KR20020010920A (ko)	1999-06-02	2002-02-06	추후제출	각질세포 성장 인자-2 제제
JP4074457B2 (ja)	2001-12-20	2008-04-09	田辺三菱製薬株式会社	ヘパリン溶液入りプレフィルドシリンジ製剤およびその製造方法
MXPA04009037A (es) *	2002-03-20	2005-01-25	Pharmacia Corp	Formulacion de eplerenona de almacenamiento estable.
AUPS188302A0 (en) *	2002-04-22	2002-05-30	Fujisawa Pharmaceutical Co., Ltd.	Pharmaceutical composition
JP2003321364A (ja) *	2002-05-07	2003-11-11	Eisai Co Ltd	シクロデキストリンにより可溶化及び安定化された抗腫瘍剤含有組成物
WO2003094889A1 (fr)	2002-05-13	2003-11-20	Daiichi Pharmaceutical Co., Ltd.	Produit de lyophilisation
DE10228049A1 (de) *	2002-06-24	2004-01-15	Merck Patent Gmbh	Flüssige Zubereitung enthaltend Oligopeptide
US7361683B2 (en)	2004-11-24	2008-04-22	Yung Shin Pharm. Ind., Co., Ltd	Paclitaxel aqueous injection solution and methods for preparing the same

2007
- 2007-06-28 CN CN2007800322662A patent/CN101578103B/zh not_active Expired - Fee Related
- 2007-06-28 CA CA2656604A patent/CA2656604C/en not_active Expired - Fee Related
- 2007-06-28 KR KR1020097001274A patent/KR101286038B1/ko not_active Expired - Fee Related
- 2007-06-28 AU AU2007266063A patent/AU2007266063B2/en not_active Ceased
- 2007-06-28 ES ES07767796T patent/ES2378279T3/es active Active
- 2007-06-28 PL PL07767796T patent/PL2047857T3/pl unknown
- 2007-06-28 BR BRPI0713080-5A patent/BRPI0713080A2/pt not_active Application Discontinuation
- 2007-06-28 WO PCT/JP2007/063003 patent/WO2008001849A1/ja not_active Ceased
- 2007-06-28 SI SI200730847T patent/SI2047857T1/sl unknown
- 2007-06-28 RU RU2009102803/15A patent/RU2462261C2/ru not_active IP Right Cessation
- 2007-06-28 EP EP07767796A patent/EP2047857B1/en not_active Not-in-force
- 2007-06-28 DK DK07767796.1T patent/DK2047857T3/da active
- 2007-06-28 US US12/306,663 patent/US7968588B2/en not_active Expired - Fee Related
- 2007-06-28 AT AT07767796T patent/ATE539761T1/de active
- 2007-06-28 JP JP2008522624A patent/JP5272126B2/ja not_active Expired - Fee Related
- 2007-06-28 PT PT07767796T patent/PT2047857E/pt unknown
- 2007-06-28 MX MX2009000155A patent/MX2009000155A/es active IP Right Grant

Also Published As

Publication number	Publication date
DK2047857T3 (da)	2012-02-27
CN101578103B (zh)	2013-09-25
AU2007266063B2 (en)	2011-09-08
PT2047857E (pt)	2012-03-15
US7968588B2 (en)	2011-06-28
CN101578103A (zh)	2009-11-11
EP2047857B1 (en)	2012-01-04
CA2656604C (en)	2014-01-07
RU2009102803A (ru)	2010-08-10
RU2462261C2 (ru)	2012-09-27
BRPI0713080A2 (pt)	2012-10-09
CA2656604A1 (en)	2008-01-03
ATE539761T1 (de)	2012-01-15
ES2378279T3 (es)	2012-04-10
JP5272126B2 (ja)	2013-08-28
KR20090030317A (ko)	2009-03-24
US20090258920A1 (en)	2009-10-15
JPWO2008001849A1 (ja)	2009-11-26
EP2047857A4 (en)	2010-05-26
EP2047857A1 (en)	2009-04-15
MX2009000155A (es)	2009-03-25
AU2007266063A1 (en)	2008-01-03
WO2008001849A1 (en)	2008-01-03
SI2047857T1 (sl)	2012-03-30
KR101286038B1 (ko)	2013-07-19

Publication	Publication Date	Title
SI2047857T1 (sl)	2012-03-30	Sredstvo za injiciranje ki vsebuje antibiotik in raztopina za injiciranje ki vsebuje to sredstvo
ECSP077250A (es)	2007-03-29	Solución para infusión de dihidropteridinonas estabilizada para el almacenamiento
WO2009097443A3 (en)	2009-12-10	Liquid formulations of compounds active at sulfonylurea receptors
PT2038290E (pt)	2013-12-10	Moduladores de receptor do tipo toll 7
SG160364A1 (en)	2010-04-29	Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
IL291556B1 (en)	2023-10-01	Methods and compositions for administration of arylsulfatase A to the central nervous system
MX338685B (es)	2016-04-26	Formulaciones de solucion intravenosa de posaconacol estabilizadas mediante beta-ciclodextrina sustituida.
MX2010004169A (es)	2010-10-05	Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
MXPA03011480A (es)	2004-03-18	Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
BRPI0418474A (pt)	2007-06-19	solução aquosa parenteral estável
RS20070461A (sr)	2008-11-28	Injektibilne kompozicije i postupak za njihovo dobijanje
EP1354602A4 (en)	2004-05-06	MEDICAL COMPOSITIONS WITH DIURETIC AGENT AND IMPROVING INSULIN RESISTANCE
TW200735864A (en)	2007-10-01	Immediate release pharmaceutical formulation
ZA202210779B (en)	2025-02-26	Composition comprising trabectedin and an amino acid
SG146687A1 (en)	2008-10-30	Drug containing (2r)-2-propyloctanoic acid as the active ingredient
JPH0517431A (ja)	1993-01-26	安定化システイン溶液
DE3942142A1 (de)	1991-06-27	Stabilisierung von glykosyliertem t-pa
UA93365C2 (ru)	2011-02-10	Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
MX2007015171A (es)	2008-04-22	Formulacion que comprende farnesil dibenzodiazepinona y un tensoactivo farmaceuticamente aceptable.
WO2012120337A1 (en)	2012-09-13	Aqueous paracetamol compositions and method of preparation
CO6270205A2 (es)	2011-04-20	Formulacion que contiene un compuesto inhibidor de quinasa dependiente de ciclina y metodo para tratar tumores utilizando el mismo
BRPI0414968A (pt)	2006-11-07	preparação de infusão contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo
NZ770000A (en)	2024-08-30	Aqueous formulation comprising 1-(4-{ [4-(dimethylamino)piperidin-1-yl]carbonyl} phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
JP2011111420A (ja)	2011-06-09	ソフトコンタクトレンズ用眼科組成物
RU2007122549A (ru)	2008-12-20	Способ профилактики гнойных осложнений при панкреонекрозе